A convergent approach to the pharmacology of tetrahydroisoquinolines.
D000818:Animals; D003975:Diazepam / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism*; D007546:Isoquinolines / Q000494:pharmacology*; D007700:Kinetics; D009270:Naloxone / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*; D012490:Salsoline Alkaloids / Q000494:pharmacology; D013134:Spiperone / Q000378:metabolism; D044005:Tetrahydroisoquinolines; D013765:Tetrahydropapaveroline / Q000494:pharmacology
D007546:Isoquinolines; D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D012490:Salsoline Alkaloids; D044005:Tetrahydroisoquinolines; D009270:Naloxone; D013765:Tetrahydropapaveroline; D013134:Spiperone; C014843:1,2,3,4-tetrahydroisoquinoline; D003975:Diazepam